A Phase 1, Randomized, Parallel-group, Open-label Study to Evaluate the Effect of Cyclosporine on the Single-dose Pharmacokinetics of Ozanimod and Major Active Metabolites in Healthy Adult Subjects
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Ozanimod (Primary) ; Ciclosporin
- Indications Crohn's disease; Multiple sclerosis; Ulcerative colitis
- Focus Pharmacokinetics
- Sponsors Celgene Corporation
Most Recent Events
- 20 Aug 2020 Status changed from recruiting to completed.
- 06 Nov 2019 New trial record